Comparison of effectiveness and safety of Topical clindamycin vs minocycline vs ozenoxacin in patients of Acne vulgaris
- Conditions
- Health Condition 1: L700- Acne vulgaris
- Registration Number
- CTRI/2024/03/064118
- Lead Sponsor
- OT APPLICABLE
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
All patients with Mild papulopustular Acne fairly localized inflamed and non-inflamed lesions, superficial inflammatory lesions being less than 5mm in diameter according to European evidence based S3 acne guidelines
Patients with mild comedonal acne
Patients with moderate or severe acne
Patients who have been regularly using anti acne medications since the last 30 days
Patients with acne conglobate, acne fulminans or drug-induced acne
Patients with history of hypersensitivity to clindamycin, minocycline or ozenoxacin
Patients who are unwilling or unable to comply with the study proceedings to give written, informed consent
Pregnant or lactating women
Patients with history of photosensitivity
Hormonal or endocrine or autoimmune abnormality
Topical Steroid Dependent Face
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method number of total lesion count, seperating the inflammatory and non-inflammatory lesions, evaluators global acne severity score, investigators global assessment score, patients assessment scoreTimepoint: every monthly for 3 months
- Secondary Outcome Measures
Name Time Method presence of scaling, erythema, burning, itching, stingingTimepoint: every monthly for 3 months